恶性肿瘤患者焦虑症患者采用柴桂龙牡汤加减联合黛力新治疗的效果观察
|
摘要
目的:研究分析对恶性肿瘤患者焦虑症患者施予柴桂龙牡汤加减联合黛力新的价值及效果。方法:随机抽取我院恶性肿瘤伴焦虑症患者95例作为本次研究对象,抽取时间为2015年05月至2016年12月期间,将其随机分为两组,其中,对照组47例服用黛力新进行治疗,研究组48例采用柴桂龙牡汤加减联合黛力新治疗,比较两组患者治疗后的情况。结果:治疗后,研究组患者的汉密顿抑郁量表(HAMD)评分与对照组患者比较差异明显,P<0.05;同时,研究组患者治疗总有效率高达93.75%,与对照组患者82.98%比较差异具备统计学意义,P<0.05。结论:恶性肿瘤患者焦虑症患者采用柴桂龙牡汤加减联合黛力新治疗的效果明确,值得全方位推行与运用。
Objective: To study and analyze the value and effect of applying Chaigui Longmu decoction combined with Deli in patients with anxiety disorder of malignant tumor. Methods: Ninety-five patients with malignant tumor and anxiety disorder in our hospital were randomly selected from May 2015 to December 2016. The patients were randomly divided into two groups: the control group(47 cases) was treated with Delaxine. The study group(48 cases) was treated with Chaiguilongmu decoction combined with Delixin, and compared the two groups after treatment. Results: After treatment, the(HAMD) score of Hamilton Depression scale in the study group was significantly higher than that in the control group(P<0.05).And the total effective rate of the study group was as high as 93.75%.The difference was statistically significant compared with the control group(82.98%)(P<0.05). Conclusion: The treatment of anxiety disorder patients with malignant tumor by Qi-Guilong Mu decoction combined with DeLixin has definite effect and deserves to be carried out and applied in all directions.
Objective: To study and analyze the value and effect of applying Chaigui Longmu decoction combined with Deli in patients with anxiety disorder of malignant tumor. Methods: Ninety-five patients with malignant tumor and anxiety disorder in our hospital were randomly selected from May 2015 to December 2016. The patients were randomly divided into two groups: the control group(47 cases) was treated with Delaxine. The study group(48 cases) was treated with Chaiguilongmu decoction combined with Delixin, and compared the two groups after treatment. Results: After treatment, the(HAMD) score of Hamilton Depression scale in the study group was significantly higher than that in the control group(P<0.05).And the total effective rate of the study group was as high as 93.75%.The difference was statistically significant compared with the control group(82.98%)(P<0.05). Conclusion: The treatment of anxiety disorder patients with malignant tumor by Qi-Guilong Mu decoction combined with DeLixin has definite effect and deserves to be carried out and applied in all directions.
引文
[1]谭萍,尤久红,杨丽琼.循证护理在腹腔热灌注化疗治疗恶性肿瘤患者中应用效果评价[J].中外医疗,2014,13(6):354-355.
[2]张明园,何燕玲.精神科评定量表手册[J].湖南科学技术出版社,2015.
[3]国家中医药管理局.中医病证诊断疗效标准[J].南京大学出版社,1994,24(5):51-52.
[4]冯婷婷,凌孙彬,方美玉.发生血栓的恶性肿瘤患者抗肿瘤治疗前的外周血液学特点分析[J].中国肿瘤,2015,11(10):221-225.
[5]王京晓,殷东风,高宏,等.中西医结合治疗恶性肿瘤并发血栓性水肿系统综述[J].实用中医内科杂志,2015,01(19):16-17.
[6]张寅,谢雁鸣,陈岑,等.基于关联规则Apriori算法的真实世界复方苦参注射液治疗恶性肿瘤联合用药药理作用特征的回顾分析[J].中国中药杂志,2017,42(2):378-384.
[7]鱼麦侠,陈捷,蔡绪明.柴桂龙牡汤加减联合黛力新治疗恶性肿瘤伴焦虑的疗效观察[J].陕西中医,2016,12(5):1134-1135.
[8]朱旭,宋凤丽,吴晓丽,等.生脉散加味联合树突细胞-细胞因子诱导杀伤细胞免疫治疗恶性肿瘤后辅助性T细胞的变化及意义[J].中华中医药杂志,2015,30(7):2580-2582.
[9]赵佳,曲秀娟,李智,等.吉西他滨的固定速率输注与标准速率输注治疗晚期恶性肿瘤疗效及安全性的Meta分析[J].沈阳药科大学学报,2015,32(6):475-483.
[10]陈洁仪,欧阳惠娴,吴琼好,等.临床护理路径联合气压治疗仪预防妇科恶性肿瘤根治术术后下肢深静脉血栓形成的效果[J].现代医院,2016,16(6):867-869.
[11]肖宇,马力文,曹宝山,等.肝动脉灌注化疗联合XELOX方案治疗胃肠道恶性肿瘤肝转移的疗效及安全性分析[J].中国微创外科杂志,2016,16(1):5-8.
[12]杨建刚,张琰君,陈继正,等.50例头颈部恶性肿瘤放疗患者营养支持、心理干预及人文照护综合治疗的疗效观察[J].现代肿瘤医学,2017,25(24):3966-3970.
[13]刘亚欣,谢雁鸣,张寅,等.复方苦参注射液治疗食管恶性肿瘤临床应用特征:一项基于医院信息系统电子医疗数据的真实世界研究[J].中国中药杂志,2017,42(15):2877-2882.
[14]李澄,谢雁鸣,张寅,等.基于关联规则Apriori算法的真实世界复方苦参注射液治疗乳腺恶性肿瘤西药联合应用特征研究[J].中南药学,2017,15(11):1513-1519.
[15]黄爱军,谭必勇,张兴强,等.CT导向下125I粒子植入联合无水乙醇碘化油混合液介入治疗治疗原发性腹膜后恶性肿瘤的疗效分析[J].现代肿瘤医学,2017,25(10):1612-1615.
[2]张明园,何燕玲.精神科评定量表手册[J].湖南科学技术出版社,2015.
[3]国家中医药管理局.中医病证诊断疗效标准[J].南京大学出版社,1994,24(5):51-52.
[4]冯婷婷,凌孙彬,方美玉.发生血栓的恶性肿瘤患者抗肿瘤治疗前的外周血液学特点分析[J].中国肿瘤,2015,11(10):221-225.
[5]王京晓,殷东风,高宏,等.中西医结合治疗恶性肿瘤并发血栓性水肿系统综述[J].实用中医内科杂志,2015,01(19):16-17.
[6]张寅,谢雁鸣,陈岑,等.基于关联规则Apriori算法的真实世界复方苦参注射液治疗恶性肿瘤联合用药药理作用特征的回顾分析[J].中国中药杂志,2017,42(2):378-384.
[7]鱼麦侠,陈捷,蔡绪明.柴桂龙牡汤加减联合黛力新治疗恶性肿瘤伴焦虑的疗效观察[J].陕西中医,2016,12(5):1134-1135.
[8]朱旭,宋凤丽,吴晓丽,等.生脉散加味联合树突细胞-细胞因子诱导杀伤细胞免疫治疗恶性肿瘤后辅助性T细胞的变化及意义[J].中华中医药杂志,2015,30(7):2580-2582.
[9]赵佳,曲秀娟,李智,等.吉西他滨的固定速率输注与标准速率输注治疗晚期恶性肿瘤疗效及安全性的Meta分析[J].沈阳药科大学学报,2015,32(6):475-483.
[10]陈洁仪,欧阳惠娴,吴琼好,等.临床护理路径联合气压治疗仪预防妇科恶性肿瘤根治术术后下肢深静脉血栓形成的效果[J].现代医院,2016,16(6):867-869.
[11]肖宇,马力文,曹宝山,等.肝动脉灌注化疗联合XELOX方案治疗胃肠道恶性肿瘤肝转移的疗效及安全性分析[J].中国微创外科杂志,2016,16(1):5-8.
[12]杨建刚,张琰君,陈继正,等.50例头颈部恶性肿瘤放疗患者营养支持、心理干预及人文照护综合治疗的疗效观察[J].现代肿瘤医学,2017,25(24):3966-3970.
[13]刘亚欣,谢雁鸣,张寅,等.复方苦参注射液治疗食管恶性肿瘤临床应用特征:一项基于医院信息系统电子医疗数据的真实世界研究[J].中国中药杂志,2017,42(15):2877-2882.
[14]李澄,谢雁鸣,张寅,等.基于关联规则Apriori算法的真实世界复方苦参注射液治疗乳腺恶性肿瘤西药联合应用特征研究[J].中南药学,2017,15(11):1513-1519.
[15]黄爱军,谭必勇,张兴强,等.CT导向下125I粒子植入联合无水乙醇碘化油混合液介入治疗治疗原发性腹膜后恶性肿瘤的疗效分析[J].现代肿瘤医学,2017,25(10):1612-1615.